Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome

ETSURO ITO, MIKIO KASAI, YASOHIDE HAYASHI, TSUTOMU TOKI, KOJI ARAI, SHINKICHI YOKOYAMA, Koji Kato, NAOKI TACHIBANA, MASAYUKI YAMAMOTO, MASARU YOKOYAMA

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Summary. Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study. Erythroid‐specific mRNAs encoding 7‐globin and erythroid 6‐aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA‐1 and GATA‐2 are expressed in all these cases. These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.

Original languageEnglish
Pages (from-to)607-614
Number of pages8
JournalBritish Journal of Haematology
Volume90
Issue number3
DOIs
Publication statusPublished - Jan 1 1995
Externally publishedYes

Fingerprint

Leukemia, Megakaryoblastic, Acute
Gene Expression
Messenger RNA
Stem Cells
Phenotype
Growth
Transient Myeloproliferative Disorder of Down Syndrome

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

ITO, ETSURO., KASAI, MIKIO., HAYASHI, YASOHIDE., TOKI, TSUTOMU., ARAI, KOJI., YOKOYAMA, SHINKICHI., ... YOKOYAMA, MASARU. (1995). Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. British Journal of Haematology, 90(3), 607-614. https://doi.org/10.1111/j.1365-2141.1995.tb05591.x

Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. / ITO, ETSURO; KASAI, MIKIO; HAYASHI, YASOHIDE; TOKI, TSUTOMU; ARAI, KOJI; YOKOYAMA, SHINKICHI; Kato, Koji; TACHIBANA, NAOKI; YAMAMOTO, MASAYUKI; YOKOYAMA, MASARU.

In: British Journal of Haematology, Vol. 90, No. 3, 01.01.1995, p. 607-614.

Research output: Contribution to journalArticle

ITO, ETSURO, KASAI, MIKIO, HAYASHI, YASOHIDE, TOKI, TSUTOMU, ARAI, KOJI, YOKOYAMA, SHINKICHI, Kato, K, TACHIBANA, NAOKI, YAMAMOTO, MASAYUKI & YOKOYAMA, MASARU 1995, 'Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome', British Journal of Haematology, vol. 90, no. 3, pp. 607-614. https://doi.org/10.1111/j.1365-2141.1995.tb05591.x
ITO, ETSURO ; KASAI, MIKIO ; HAYASHI, YASOHIDE ; TOKI, TSUTOMU ; ARAI, KOJI ; YOKOYAMA, SHINKICHI ; Kato, Koji ; TACHIBANA, NAOKI ; YAMAMOTO, MASAYUKI ; YOKOYAMA, MASARU. / Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. In: British Journal of Haematology. 1995 ; Vol. 90, No. 3. pp. 607-614.
@article{ad05be28fe69442db03737af7d174f9e,
title = "Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome",
abstract = "Summary. Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study. Erythroid‐specific mRNAs encoding 7‐globin and erythroid 6‐aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA‐1 and GATA‐2 are expressed in all these cases. These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.",
author = "ETSURO ITO and MIKIO KASAI and YASOHIDE HAYASHI and TSUTOMU TOKI and KOJI ARAI and SHINKICHI YOKOYAMA and Koji Kato and NAOKI TACHIBANA and MASAYUKI YAMAMOTO and MASARU YOKOYAMA",
year = "1995",
month = "1",
day = "1",
doi = "10.1111/j.1365-2141.1995.tb05591.x",
language = "English",
volume = "90",
pages = "607--614",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Expression of erythroid‐specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome

AU - ITO, ETSURO

AU - KASAI, MIKIO

AU - HAYASHI, YASOHIDE

AU - TOKI, TSUTOMU

AU - ARAI, KOJI

AU - YOKOYAMA, SHINKICHI

AU - Kato, Koji

AU - TACHIBANA, NAOKI

AU - YAMAMOTO, MASAYUKI

AU - YOKOYAMA, MASARU

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Summary. Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study. Erythroid‐specific mRNAs encoding 7‐globin and erythroid 6‐aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA‐1 and GATA‐2 are expressed in all these cases. These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.

AB - Summary. Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study. Erythroid‐specific mRNAs encoding 7‐globin and erythroid 6‐aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA‐1 and GATA‐2 are expressed in all these cases. These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.

UR - http://www.scopus.com/inward/record.url?scp=0029040851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029040851&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.1995.tb05591.x

DO - 10.1111/j.1365-2141.1995.tb05591.x

M3 - Article

C2 - 7647001

AN - SCOPUS:0029040851

VL - 90

SP - 607

EP - 614

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -